Paraskevi Karamitsou

Paraskevi Karamitsou

Auto-generated profile, based on publicly available information

Paraskevi Karamitsou

Ear, Nose, and Throat (ENT) Department, East and North Hertfordshire Teaching NHS Trust, Stevenage, United Kingdom

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
APAlexandros Poutoglidis
Alexandros Poutoglidis
SSStavros Savvakis
Stavros Savvakis
PKParaskevi Karamitsou
Paraskevi Karamitsou
EFEvropi Forozidou
Evropi Forozidou
GPGeorge Paraskevas
George Paraskevas
ASAntonios Skalias
Antonios Skalias

9 November 2018 in European Journal of Orthopaedic Surgery & Traumatology
Verified
Journal Article
Closed access
PDF file
DKDimitrios Kitridis
Dimitrios Kitridis
PKParaskevi Karamitsou
Paraskevi Karamitsou
IGIraklis Giannaros
Iraklis Giannaros
NPNikolaos Papadakis
Nikolaos Papadakis
CSChris Sinopidis
Chris Sinopidis
PGPanagiotis Givissis
Panagiotis Givissis

9 March 2023 in Cureus
Verified
Journal Article
Open access
PDF file
PKParaskevi Karamitsou
Paraskevi Karamitsou
JSJames Philip Skliris
James Philip Skliris
SGSpyridon Gougousis
Spyridon Gougousis
AKAikaterini Karamitsou
Aikaterini Karamitsou
APAlexandros Poutoglidis
Alexandros Poutoglidis
Hepatocellular carcinoma (HCC) is the most dominant malignant neoplasm of the liver and constitutes the majority of all primary malignancies. Most reported cases of HCC occur in the developing world and are mainly associated with chronic hepatitis B and C viruses. Both hematogenous and lymphatic spreading is common in HCC. Patients with HCC might manifest extra-hepatic metastases and the lungs are the most common potential site of metastatic deposits. Rare sites of metastatic disease have also been described. Oropharyngeal metastases of HCC are rare and there are few reports available in the literature. We report a rare case of extra-hepatic metastasis of HCC to the right tonsil in an 84-year-old patient. The clinical appearance of metastatic oral lesions could be easily underestimated, and diagnosis of the primary tumor might delay. A biopsy of the oral lesion is important for an accurate diagnosis. Metastasis in the oral cavity and oropharynx of an HCC is usually evidence of widespread disease and predisposes to an ominous prognosis.

17 February 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
APAlexandros Poutoglidis
Alexandros Poutoglidis
CGChristos Georgalas
Christos Georgalas
GFGeorgios Fyrmpas
Georgios Fyrmpas
PKParaskevi Karamitsou
Paraskevi Karamitsou

23 April 2024 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
APAlexandros Poutoglidis
Alexandros Poutoglidis
EFEvropi Forozidou
Evropi Forozidou
GFGeorgios Fyrmpas
Georgios Fyrmpas
KVKonstantinos Vlachtsis
Konstantinos Vlachtsis
PKParaskevi Karamitsou
Paraskevi Karamitsou
Objective: Transoral robotic surgery total laryngectomy is a promising procedure. We conducted a systematic review to study the indications, surgical techniques and complications of this procedure.Methods: We followed the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement.Results: We concluded with 5 studies and 27 surgeries. The main indications of transoral robotic surgery total laryngectomy were selected recurrent laryngeal squamous cell carcinomas, dysfunctional larynx, and specific primary non-squamous cell carcinoma laryngeal cancers. The rate of pharyngocutaneous fistula was 20 per cent overall. In every reported cancer case, the specimen was excised within negative surgical margins. The average time of the procedure was 282.6 minutes.Conclusion: Transoral robotic surgery total laryngectomy is a safe procedure of high value. The preservation of strap muscles and hyoid bone as well as the sacrifice of less mucosa compared to the traditional technique reduces the risk of certain complications and improves the swallowing outcome.

17 November 2023 in The Laryngoscope
Verified
Journal Article
Open access
APAlexandros Poutoglidis
Alexandros Poutoglidis
EFEvropi Forozidou
Evropi Forozidou
GFGeorgios Fyrmpas
Georgios Fyrmpas
KMKonstantinos Mantsopoulos
Konstantinos Mantsopoulos
CCChrysanthos Chrysanthou
Chrysanthos Chrysanthou
PKParaskevi Karamitsou
Paraskevi Karamitsou
Objective: Mucoepidermoid carcinomas (MEC) of the larynx account for less than 1% of all laryngeal tumors. The unique features and clinical behavior of these rare entities remain unknown. To fill this knowledge gap, we performed a scoping review of every reported case of laryngeal MEC to study the clinical behavior and the treatment modalities in this rare entity. Review Methods: We followed the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses extension for scoping reviews (PRISMA‐ScR) statement. Data Sources: MedLine, Google Scholar, and Science Direct databases were searched to identify eligible studies. Results: We concluded with 25 studies and overall 66 cases. Our study revealed that the average age of cases was 55.7 years, and the range was from 12 to 81 years, with younger onset in females. Supraglottic (60%) is the most common subsite of laryngeal MEC s followed by glottis (27.3%). Supraglottic carcinomas frequently present with metastatic neck disease at the time of the initial diagnosis and require more extensive surgical approaches. Surgery with negative surgical margins seems to be the cornerstone in the treatment of MEC. Radiation therapy has not been tested widely as monotherapy but is considered a useful adjuvant modality. Conclusion: This study suggests that negative surgical margins seem to be associated to higher disease control rate and that high‐grade supraglottic cases likely benefit from addressing neck disease simultaneously. Level of Evidence: NA Laryngoscope , 134:2578–2584, 2024